To improve the permeability,improve the target specificity, minimize toxicity and side effects,and induce the efficacy of HLA-20 for treating AD patients, a leadingstrategy for a site-activated chelator acetylcholinesterase (AChE)inhibitor was designed. The gene discussed is ACHE; the disease is Alzheimer disease.